{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:29:20Z","timestamp":1762352960922,"version":"build-2065373602"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-18142-7","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:28:45Z","timestamp":1758385725000},"page":"9617-9627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Redefining Resection Margin Status and Its Implications for Adjuvant Radiotherapy in Hilar Cholangiocarcinoma: A 10-Year Retrospective Study of Recurrence Patterns"],"prefix":"10.1245","volume":"32","author":[{"given":"Su Hyung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Reum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sub","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"18142_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303\u201314.","journal-title":"Lancet."},{"key":"18142_CR2","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689\u2013700.","journal-title":"Cancer."},{"key":"18142_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archsurg.139.5.514","volume":"139","author":"DJ Rea","year":"2004","unstructured":"Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514\u201323 (discussion 523\u2013515).","journal-title":"Arch Surg."},{"key":"18142_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129\u201340.","journal-title":"Ann Surg."},{"key":"18142_CR5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1245\/ASO.2006.05.053","volume":"13","author":"S Dinant","year":"2006","unstructured":"Dinant S, Gerhards MF, Rauws EA, et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13:872\u201380.","journal-title":"Ann Surg Oncol."},{"key":"18142_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00384-014-2063-z","volume":"30","author":"S Xiang","year":"2015","unstructured":"Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159\u201371.","journal-title":"Int J Colorectal Dis."},{"key":"18142_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507\u201317 (discussion 517\u2013509).","journal-title":"Ann Surg."},{"key":"18142_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1245\/s10434-020-09105-1","volume":"28","author":"S Stremitzer","year":"2021","unstructured":"Stremitzer S, Stift J, Laengle J, et al. Prognosis and circumferential margin in patients with resected hilar cholangiocarcinoma. Ann Surg Oncol. 2021;28:1493\u20138.","journal-title":"Ann Surg Oncol."},{"key":"18142_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.hpb.2020.05.002","volume":"23","author":"L Yohanathan","year":"2021","unstructured":"Yohanathan L, Croome KP, Traynor M, et al. Significance of proximal ductal margin status after resection of hilar cholangiocarcinoma. HPB Oxford. 2021;23:109\u201317.","journal-title":"HPB Oxford."},{"key":"18142_CR10","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","volume":"40","author":"MJ Kang","year":"2016","unstructured":"Kang MJ, Jang JY, Chang J, et al. Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma. World J Surg. 2016;40:2451\u20139.","journal-title":"World J Surg."},{"key":"18142_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1245\/s10434-011-2072-x","volume":"19","author":"MA Machado","year":"2012","unstructured":"Machado MA, Makdissi FF, Surjan RC. Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique. Ann Surg Oncol. 2012;19:1324\u20135.","journal-title":"Ann Surg Oncol."},{"key":"18142_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/SLA.0000000000000584","volume":"259","author":"I Hosokawa","year":"2014","unstructured":"Hosokawa I, Shimizu H, Yoshidome H, et al. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg. 2014;259:1178\u201385.","journal-title":"Ann Surg."},{"key":"18142_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00268-013-1980-2","volume":"37","author":"F Ratti","year":"2013","unstructured":"Ratti F, Cipriani F, Ferla F, et al. Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach: toward a better outcome. World J Surg. 2013;37:1388\u201396.","journal-title":"World J Surg."},{"key":"18142_CR14","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1245\/s10434-022-12041-x","volume":"29","author":"T Lenet","year":"2022","unstructured":"Lenet T, Gilbert RWD, Smoot R, et al. Does intraoperative frozen section and revision of margins lead to improved survival in patients undergoing resection of perihilar cholangiocarcinoma? A systematic review and meta-analysis. Ann Surg Oncol. 2022;29:7592\u2013602.","journal-title":"Ann Surg Oncol."},{"key":"18142_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/cam4.693","volume":"5","author":"HT Mantel","year":"2016","unstructured":"Mantel HT, Westerkamp AC, Sieders E, et al. Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value. Cancer Med. 2016;5:1373\u201380.","journal-title":"Cancer Med."},{"key":"18142_CR16","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/cam4.920","volume":"5","author":"WJ Ma","year":"2016","unstructured":"Ma WJ, Shrestha A, Li FY. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value? Cancer Med. 2016;5:2848\u20139.","journal-title":"Cancer Med."},{"key":"18142_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.6265","volume":"263","author":"Y Omori","year":"2024","unstructured":"Omori Y, Aoki S, Ono Y, et al. Clonal analysis of metachronous double biliary tract cancers. J Pathol. 2024;263:113\u201327.","journal-title":"J Pathol."},{"key":"18142_CR18","unstructured":"Network NCC. NCCN Guidelines Version 1.2025 Biliary Tract Cancer 2025. Retrieved March 30, 2025 at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/btc.pdf."},{"key":"18142_CR19","doi-asserted-by":"publisher","first-page":"10871","DOI":"10.2147\/CMAR.S224583","volume":"11","author":"G Wang","year":"2019","unstructured":"Wang G, Wang Q, Fan X, et al. The significance of adjuvant therapy for extrahepatic cholangiocarcinoma after surgery. Cancer Manag Res. 2019;11:10871\u201382.","journal-title":"Cancer Manag Res."},{"key":"18142_CR20","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.3748\/wjg.v18.i21.2591","volume":"18","author":"S Cereda","year":"2012","unstructured":"Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol. 2012;18:2591\u20136.","journal-title":"World J Gastroenterol."},{"key":"18142_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/13651820801992666","volume":"10","author":"Y Nimura","year":"2008","unstructured":"Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB Oxford. 2008;10:130\u20133.","journal-title":"HPB Oxford."},{"key":"18142_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00534-006-1192-3","volume":"14","author":"H Maguchi","year":"2007","unstructured":"Maguchi H, Takahashi K, Katanuma A, et al. Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobil Pancreat Surg. 2007;14:441\u20136.","journal-title":"J Hepatobil Pancreat Surg."},{"key":"18142_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s005340050170","volume":"7","author":"Y Nimura","year":"2000","unstructured":"Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobil-Pancreat Surg. 2000;7:155\u201362.","journal-title":"J Hepatobil-Pancreat Surg."},{"key":"18142_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00534-009-0204-5","volume":"17","author":"SG Lee","year":"2009","unstructured":"Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobil-Pancreat Sci. 2009;17:476\u201389.","journal-title":"J Hepatobil-Pancreat Sci."},{"key":"18142_CR25","first-page":"e63648","volume":"185","author":"Z Deng","year":"2022","unstructured":"Deng Z, Zhao G, Wang Z, Yu L, Zou W, Li L, Liu R. Robotic Taj Mahal hepatectomy for hilar cholangiocarcinoma. J Vis Exp. 2022;185:e63648.","journal-title":"J Vis Exp."},{"key":"18142_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3126\/jkmc.v9i3.36585","volume":"9","author":"R Ghimire","year":"2020","unstructured":"Ghimire R, Amatya KS, Thapa P. Achieving negative margin in Bismuth III and IV hilar cholangiocarcinoma without major hepatectomy. J Kathmandu Med Coll. 2020;9:161\u20134.","journal-title":"J Kathmandu Med Coll."},{"key":"18142_CR27","doi-asserted-by":"crossref","unstructured":"Tao R, Yuan T, Cheng Q, et al. Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study. Sci China Life Sci. 2025.","DOI":"10.1007\/s11427-024-2855-x"},{"key":"18142_CR28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00432-021-03524-7","volume":"147","author":"JH Im","year":"2021","unstructured":"Im JH, Choi GH, Lee WJ, et al. Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma. J Cancer Res Clin Oncol. 2021;147:2435\u201345.","journal-title":"J Cancer Res Clin Oncol."},{"key":"18142_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","volume":"221","author":"B Groot Koerkamp","year":"2015","unstructured":"Groot Koerkamp B, Wiggers JK, Allen PJ, et al. Recurrence rate and pattern of perihilar cholangiocarcinoma after curative-intent resection. J Am Coll Surg. 2015;221:1041\u20139.","journal-title":"J Am Coll Surg."},{"key":"18142_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/bjs.6788","volume":"97","author":"A Kobayashi","year":"2010","unstructured":"Kobayashi A, Miwa S, Nakata T, et al. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56\u201364.","journal-title":"Br J Surg."},{"key":"18142_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3748\/wjg.v28.i9.948","volume":"28","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Chen WY, Zhang YQ, et al. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol. 2022;28:948\u201360.","journal-title":"World J Gastroenterol."},{"key":"18142_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1245\/s10434-016-5472-0","volume":"24","author":"G Atanasov","year":"2017","unstructured":"Atanasov G, Schierle K, Hau HM, et al. Prognostic significance of tumor necrosis in hilar cholangiocarcinoma. Ann Surg Oncol. 2017;24:518\u201325.","journal-title":"Ann Surg Oncol."},{"key":"18142_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13014-018-1024-z","volume":"13","author":"HS Choi","year":"2018","unstructured":"Choi HS, Kang KM, Jeong BK, et al. Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes. Radiat Oncol. 2018;13:85.","journal-title":"Radiat Oncol."},{"key":"18142_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3857\/roj.2016.01879","volume":"34","author":"MY Kim","year":"2016","unstructured":"Kim MY, Kim JH, Kim Y, et al. Postoperative radiotherapy appeared to improve the disease-free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence. Radiat Oncol J. 2016;34:297\u2013304.","journal-title":"Radiat Oncol J."},{"key":"18142_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5306\/wjco.v2.i2.94","volume":"2","author":"N Akamatsu","year":"2011","unstructured":"Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: advances and current limitations. World J Clin Oncol. 2011;2:94\u2013107.","journal-title":"World J Clin Oncol."},{"key":"18142_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/den.14757","volume":"36","author":"K Tomishima","year":"2024","unstructured":"Tomishima K, Fukumura Y, Isayama H. Case of hilar cholangiocarcinoma with a distal skip lesion detected by cholangioscopy. Dig Endosc. 2024;36:497\u20138.","journal-title":"Dig Endosc."},{"key":"18142_CR37","doi-asserted-by":"publisher","first-page":"14744","DOI":"10.18632\/oncotarget.4539","volume":"6","author":"G Brandi","year":"2015","unstructured":"Brandi G, Farioli A, Astolfi A, et al. Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies. Oncotarget. 2015;6:14744\u201353.","journal-title":"Oncotarget."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18142-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:17:31Z","timestamp":1762352251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18142-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["18142"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18142-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}